Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Simard

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Clinical Science (London, England : 1979)|July 17, 2019
PBI-4050 via GPR40 activation improves adenine-induced kidney injury in miceJean-François Thibodeau, Jean-Christophe Simard, Chet E Holterman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 11, 2018
PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin PathwayBrigitte Grouix, Francois Sarra-Bournet, Martin Leduc, et al.
European Journal of Medicinal Chemistry|February 21, 2020
Targeting different binding sites in the CFTR structures allows to synergistically potentiate channel activityLionel Froux, Ahmad Elbahnsi, Benjamin Boucherle, et al.
Scientific Reports|July 31, 2020
Fatty acid mimetic PBI-4547 restores metabolic homeostasis via GPR84 in mice with non-alcoholic fatty liver diseaseJean-Christophe Simard, Jean-François Thibodeau, Martin Leduc, et al.
The American Journal of Pathology|February 19, 2018
A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84Lyne Gagnon, Martin Leduc, Jean-Francois Thibodeau, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Clinical Science (London, England : 1979)|July 17, 2019
PBI-4050 via GPR40 activation improves adenine-induced kidney injury in miceJean-François Thibodeau, Jean-Christophe Simard, Chet E Holterman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 11, 2018
PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin PathwayBrigitte Grouix, Francois Sarra-Bournet, Martin Leduc, et al.
European Journal of Medicinal Chemistry|February 21, 2020
Targeting different binding sites in the CFTR structures allows to synergistically potentiate channel activityLionel Froux, Ahmad Elbahnsi, Benjamin Boucherle, et al.
Scientific Reports|July 31, 2020
Fatty acid mimetic PBI-4547 restores metabolic homeostasis via GPR84 in mice with non-alcoholic fatty liver diseaseJean-Christophe Simard, Jean-François Thibodeau, Martin Leduc, et al.
The American Journal of Pathology|February 19, 2018
A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84Lyne Gagnon, Martin Leduc, Jean-Francois Thibodeau, et al.
Pageof 5